In this article, Aptar Pharma uses inductively coupled plasma optical emission spectrometry (ICP-OES) to demonstrate that our proprietary manufacturing process optimizes the distribution of silicone oil on our PremiumCoat®. By limiting the quantity of silicone that comes in contact with the drug product, PremiumCoat® derisks the development of sensitive drugs.
Learn more about PremiumCoat® Platform
This Might Also Be of Interest

Aptar Pharma reviews the importance of silicone levels on vial stoppers
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Derisking the Development of Prefilled Syringe Delivery
Publications, Pharmaceutical, Product Solutions, Market Insights

Coating Technology – Combining a State-of-the-Art Bromobutyl Formulation With a...
Publications, Pharmaceutical, Innovation & Insights, Product Solutions

The Go-To Drug Delivery Expert
Brochures, Pharmaceutical, Brand Differentiation, Product Solutions, Sustainability, Device Innovations